Harnessing Nature for Faster mRNA Vaccine Manufacturing

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 25, 2020 at 10:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via Manufacturing capacity is often decried as a major bottleneck in administering COVID-19 vaccines to a global population of 7.8 billion. For mRNA vaccines, which can make 1 million doses in a 2-liter bioreactor, the bottleneck is the availability of raw materials, not bioreactors.

    article source